Safety and efficacy of eplerenone in patients at high risk for hyperkalemia and/or worsening renal function. analyses of the emphasis-hf study subgroups (eplerenone in mild patients hospitalization and survival study in heart failure)

Eschalier, R. et al. (2014) Safety and efficacy of eplerenone in patients at high risk for hyperkalemia and/or worsening renal function. analyses of the emphasis-hf study subgroups (eplerenone in mild patients hospitalization and survival study in heart failure). Rational Pharmacotherapy in Cardiology, 10(1), pp. 106-115. (doi: 10.20996/1819-6446-2014-10-1-106-115)

Abstract

Translation articles: R. Eschalier, J.J.V. McMurray, K. Swedberg, D.J. van Veldhuisen, H. Krum, S.J. Pocock, H. Shi, J. Vincent, P. Rossignol, F. Zannad, B. Pitt, for the EMPHASIS-HF Investigators “Safety and Efficacy of Eplerenone in Patients at High Risk for Hyperkalemia and/or Worsening Renal Function. Analyses of the EMPHASIS-HF Study Subgroups (Eplerenone in Mild Patients Hospitalization And SurvIval Study in Heart Failure)” J Am Coll Cardiol 2013;62(17):1585-93; http://dx.doi.org/10.1016/j.jacc.2013.04.086

• Item Type: Articles
• Status: Published
• Refereed: Yes
• Glasgow Author(s) Enlighten ID: McMurray, Professor John
• Authors: Eschalier, R., McMurray, J.J.V., Swedberg, K., van Veldhuisen, D.J., Krum, H., Pocock, S.J., Shi, H., Vincent, J., Rossignol, P., Zannad, F., and Pitt, B.
• College/School: College of Medical Veterinary and Life Sciences > School of Cardiovascular & Metabolic Health
• Journal Name: Rational Pharmacotherapy in Cardiology
• Publisher: Vserossiiskoe Nauchnoe Obshchestvo Kardiologov
• ISSN: 1819-6446
• ISSN (Online): 2225-3653
• Copyright Holders: Copyright © 2013 by the American College of Cardiology Foundation
• First Published: First published in Rational Pharmacotherapy in Cardiology 10(1):106-115
• Publisher Policy: Reproduced under a Creative Commons license